Literature DB >> 20494482

[The regulation of pedestrian traffic lights in Spain: do older people have enough time to cross the road?].

Román Romero Ortuño1.   

Abstract

INTRODUCTION: In Spain, citizen complaints continue to be filed about pedestrian traffic lights in urban areas not providing enough time to cross roads safely, especially by the elderly and people with disabilities. This is despite the existence of accessibility laws in Spanish regions, the most favorable being to establish that pedestrian traffic lights should be regulated according to a pedestrian crossing speed of 0.7 meters per second (m/s). The Survey of Health, Ageing and Retirement in Europe (SHARE, http://www.share-project.org) measured the normal walking speed of a nationally representative sample of Spanish people of 75 or more years of age. Our study compared the median walking speed of this sample against the reference speed of 0.7 m/s.
MATERIAL AND METHODS: Spanish sample of the second wave of SHARE (version 2.2.0), including 244 subjects of 75 or more years of age of which 121 were women and 123 men.
RESULTS: The median walking speed in women was 0.40 m/s, and in men it was 0.60 m/s. The analysis of frequencies showed that 75.2% (N=91) of women and 66.7% (N=82) of men had individual walking speeds of less than 0.7 m/s. The reference speed that would include the 80% of women and men in the sample would be 0.25 and 0.31 m/s, respectively.
CONCLUSION: The reference walking speed of 0.7 m/s excludes a great proportion of older people. Urgent corrective measures are needed to avoid discrimination and protect the safety of this growing sector of the population.
Copyright © 2009 SEGG. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494482     DOI: 10.1016/j.regg.2010.04.002

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN: 0211-139X


  1 in total

1.  Factors influencing walking trips. Evidence from Gdynia, Poland.

Authors:  Marcin Wolek; Michal Suchanek; Tomasz Czuba
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.